Medication adherence and quality of life in pediatric inflammatory bowel disease

被引:109
作者
Hommel, Kevin A. [1 ,2 ]
Davis, Christine M. [3 ]
Baldassano, Robert N. [3 ,4 ]
机构
[1] Cincinnati Childrens Hosp, Med Ctr, Ctr Promot Treatment Adherence & Self Management, Behav Med & Clin Psychol, Cincinnati, OH 45229 USA
[2] Univ Cincinnati, Coll Med, Cincinnati, OH 45221 USA
[3] Childrens Hosp Philadelphia, Philadelphia, PA USA
[4] Univ Penn, Sch Med, Philadelphia, PA 19104 USA
关键词
adherence; compliance; inflammatory bowel disease; quality of life;
D O I
10.1093/jpepsy/jsn022
中图分类号
B844 [发展心理学(人类心理学)];
学科分类号
040202 [发展与教育心理学];
摘要
Objective To examine the relationship between medication adherence and quality of life (QOL) in adolescent patients with inflammatory bowel disease (IBD) utilizing a multimethod adherence assessment approach. Methods Medication adherence in 36 adolescents with IBD was assessed via interviews, pill counts, and biological assays. QOL was assessed via patient and parent report. Pediatric gastroenterologists provided disease severity assessments. Results Hierarchical multiple regression analyses revealed that adherence contributed significant variance to patient-reported QOL but not parent-reported QOL. Nonadherence to 6-MP/azathioprine was related to poorer patient-reported physical health QOL. Greater self-reported 5-ASA adherence was related to poorer overall psychological health QOL, and particularly social functioning QOL. Conclusions Results provide preliminary support for the negative effects of 6-MP/azathioprine nonadherence on QOL and an inverse relationship between 5-ASA adherence and QOL in this population. Adherence burden in patients and the utility of multimethod adherence assessment in research are discussed.
引用
收藏
页码:867 / 874
页数:8
相关论文
共 29 条
[1]
[Anonymous], 1985, PSYCHOPHARMACOL BULL
[2]
[Anonymous], 2009, Adherence to pediatric medical regimens. Issues in Clinical Child Psychology
[3]
[Anonymous], 2001, MEDICAL ADHERE UNPUB
[4]
Is treatment adherence associated with better quality of life in children with sickle cell disease? [J].
Barakat, LP ;
Lutz, M ;
Smith-Whitley, K ;
Ohene-Frempong, K .
QUALITY OF LIFE RESEARCH, 2005, 14 (02) :407-414
[5]
Therapeutic drug monitoring of azathioprine and 6-mercaptopurine metabolites in Crohn disease [J].
Belaiche, J ;
Desager, JP ;
Horsmans, Y ;
Louis, E .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2001, 36 (01) :71-76
[6]
BERG JS, 1993, ANN PHARMACOTHER, V27, pS1
[7]
*CCFA, 2008, WHAT IS IBD RAC ETHN
[8]
Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297
[9]
Quantitation of B-thioguanine in peripheral blood leukocyte DNA in Crohn's disease patients on maintenance 6-mercaptopurine therapy [J].
Cuffari, C ;
Seidman, EG ;
Latour, S ;
Theoret, Y .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1996, 74 (05) :580-585
[10]
DROSSMAN DA, 2003, KIRSNERS INFLAMMATOR, P340